Skip to main content

BaselArea.swiss Presents the DayOne Acceleration Program Supported by Fondation Botnar

| News

BaselArea.swiss Presents the DayOne Acceleration Program Supported by Fondation Botnar

29.05.2018

Seeking brilliant project ideas that, combined with digital technologies, healthcare expertise and entrepreneurial spirit, will help solve the health challenges and unmet needs of young people. Selected projects will receive up to 70,000 CHF in non-dilutive funding.

DayOne, the swiss innovation hub for precision medicine and digital health run by BaselArea.swiss, is launching an acceleration program supported by Fondation Botnar. Applications are now open to project ideas improving the wellbeing and health of children and adolescents worldwide.

The acceleration program will include a tailor-made mentoring program, access to DayOne industry experts and collaborative workspace at the DayOne Lab. Selected projects will receive up to 70,000 CHF in non-dilutive funding. We are looking for brilliant ideas that, combined with digital technologies, healthcare expertise and entrepreneurial spirit, will help solve the health challenges and unmet needs of young people.

The program welcomes healthcare innovators, start-ups and entrepreneurs as well as intrapreneurs willing to accelerate their project outside of their corporate environment.

We at DayOne believe that healthcare is moving from the hospital to the living room and changing from a sick repair system to a health system. Therefore, Fondation Botnar through the DayOne Acceleration program is reaching out to healthcare innovators who are passionate about developing new approaches to improve the wellbeing and health of children and adolescents around the world in any setting. The solutions should have a strong impact delivering health outcomes, while being cost-efficient, scalable and sustainable.

The program will support teams and individuals who strive to:

  • go beyond research and create minimal viable healthcare products and services
  • target health Issues with a special focus on pediatrics and/or adolescents
  • enable frontline work to deliver better health outcomes
  • lower the healthcare costs and be scalable and therefore making their solution suitable for all markets including in emerging countries.

The solutions should embrace a human centric approach focusing on young people and make appropriate use of Digital Technologies (Mobile Apps, AI, Blockchain etc.)

Participants will have the opportunity to drive their project idea forward in a collaborative way engaging with the healthcare innovation ecosystem of the Basel Region. Applicants should therefore be willing to be present in the Basel region and be able to dedicate sufficient personal time to execute on their idea during the six-month period of the DayOne Acceleration Program.

The deadline for the initial application is July 31st.

An initial selection of projects will be made in early August. The selected projects will participate at the DayOne conference on September 11th in Basel where they will receive valuable feedback on their project idea from healthcare innovation experts. They will then have 3 weeks to complete a final application by September 30 th. The formal acceleration program will start no later than January 14 th 2019 and be for a period of 6 months.

Registration and more information

Get involved now, fill out the application.
For more Information, please see our FAQs.

About Fondation Botnar

Fondation Botnar is a charitable foundation established with the core purpose to support children’s basic needs throughout the world. It was founded in Basel in 2003 to continue the philanthropic work of the Botnar family. Its focus is health, nutrition and education.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

BOOM Summit in Basel accelerates health technology

The BOOM Summit at Messe Basel in April 2024 will be a completely new kind of healthcare conference. The first...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More

CSL joins Basel Area biotech cluster

The research and development department of the globally active Australian biotech company CSL has moved into a new office in...
Read More

Palto Therapeutics receives 150,000 Swiss francs from Venture Kick

Allschwil-based Palto Therapeutics has won the third stage of the Venture Kick promotional funding program. As such, the company now...
Read More

Roche uses artificial intelligence for cancer diagnosis

Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field of artificial intelligence. The goal...
Read More

Cimeio collaborating with the University of Pennsylvania

The Basel-based startup Cimeio has been offered an exceptional opportunity for a preclinical research collaboration with the University of Pennsylvania,...
Read More

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Forty51 Ventures invests to found Mysthera Therapeutics

Mysthera Therapeutics AG has been founded in Basel. Forty51 Ventures, a venture capital firm also based in Basel, has provided...
Read More

Spexis receives capital commitment of 2.5 million US dollars

Investors have made an additional capital commitment to Spexis AG, based in the Basel Area. With an extra 2.5 million...
Read More

Worg secures financing of 130 million Swiss francs

The Chinese biopharmaceutical firm Worg Pharma, whose European headquarters are located in the Basel Area, has secured gross proceeds equivalent...
Read More

Tenpoint aims to make vision loss reversible

The startup Tenpoint Therapeutics has started operations with a funding round of 70 million US dollars. It works to make...
Read More
1 2 3 13

Do you have a question? We'd like to hear from you.